FTY720 induces cell cycle arrest and apoptosis of rat glomerular mesangial cells.

Molecular Biology Reports
Jingyu JiangJianhua Zhou

Abstract

The present study aimed to examine the effect of FTY720, a new immunosuppressive agent, on the proliferation and apoptosis of glomerular mesangial cells (GMC), and investigate the underlying mechanisms. Cultured rat GMC were treated by FTY720, and the cell viability, apoptosis and cell cycle progression were examined. Furthermore, cell cycle related gene expression profile was analyzed by cDNA microarray, and the protein expression of cell cycle related genes as well as Bax and Bcl-2 were examined by Western blot. The results showed that FTY720 inhibited GMC proliferation and induced apoptosis of GMC in a dose- and time-dependent manner, and induced G(1) phase cell cycle arrest in GMC in a dose-dependent manner as well. cDNA microarray analysis revealed that FTY720 regulated the expression of cell cycle-related gene. Western blot analysis showed that FTY720 induced the downregulation of cyclin D1, cyclin E, CDK2, CDK4, Bcl-2 and E2F1 and the upregulation of Kip1/p27, Cip1/p21, Bax and Rb in GMC in a dose-dependent manner. These results demonstrated that FTY720 could inhibit the proliferation of GMC through inducing cell cycle arrest and apoptosis, probably via the regulation of the expression of cell cycle-related genes and Bax...Continue Reading

References

Feb 27, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A YoshimuraT Ideura
Jun 3, 1999·Experimental Nephrology·S J Shankland, M Al'Douahji
May 24, 2000·Immunopharmacology·Y NagaharaT Shinomiya
Jun 29, 2001·Japanese Journal of Cancer Research : Gann·Y NagaharaT Shinomiya
Oct 19, 2001·International Immunopharmacology·M FujinoS Suzuki
Feb 22, 2002·International Journal of Cancer. Journal International Du Cancer·Sompol PermpongkosolAkihiko Okuyama
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Masayuki FujinoSeiichi Suzuki
Nov 14, 2002·British Journal of Pharmacology·Yukitoshi NagaharaTakahisa Shinomiya
Jun 5, 2003·Springer Seminars in Immunopathology·Siân V GriffinStuart J Shankland
Nov 25, 2003·Seminars in Nephrology·Siân V GriffinStuart J Shankland
Aug 17, 2005·Current Drug Targets. Inflammation and Allergy·Carmen Gómez-GuerreroJesús Egido
Apr 26, 2006·Transplant Immunology·Naohito IsoyamaKatsusuke Naito
Sep 5, 2006·Cellular and Molecular Life Sciences : CMLS·X-B QiuL Wang
Oct 24, 2007·Transplantation Proceedings·T BöhlerM Thomsen
Feb 5, 2008·Molecular Cell·Mayumi KitagawaFrank McCormick
May 27, 2010·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Henrik PotteckBurkhard Kleuser
May 28, 2010·Journal of Cellular Biochemistry·Tongsen ZhengLianxin Liu
Oct 20, 2010·International Journal of Molecular Sciences·Fang WangShaoheng He
May 10, 2011·Molecular Biology Reports·Hong Rong FeiFeng Ze Wang

❮ Previous
Next ❯

Citations

Mar 16, 2017·The Journal of Investigative Dermatology·Fen ShiBing Tang
Jan 31, 2019·American Journal of Physiology. Renal Physiology·Wei GongSongming Huang
Oct 9, 2013·Oncology Reports·Li ZhangYuan Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis